Atlas Trials

Non-Polymer-Based, Rapamycin-Eluting Stents to Prevent Restenosis

Clinical trial NCT00152308 · TERMINATED

Trial details

NCT number
NCT00152308
Sponsor
Translumina GmbH
Status
TERMINATED
Phase
Phase 4
Study type
INTERVENTIONAL
Coronary Disease
Start date
2004-12-01
Enrollment
333

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.